UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Porter, DL; Alyea, EP; Antin, JH; DeLima, M; Estey, E; Falkenburg, JHF; Hardy, N; ... van Besien, K; + view all (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. BIOL BLOOD MARROW TR , 16 (11) 1467 - 1503. 10.1016/j.bbmt.2010.08.001.

Full text not available from this repository.

Abstract

Relapse is a major cause of treatment failure after allogeneic hematopoietic stern cell transplantation (alloHSCT). Treatment options for relapse have been inadequate, and the majority of patients ultimately die of their disease. There is no standard approach to treating relapse after alloHSCT. Withdrawal of immune suppression and donor lymphocyte infusions are commonly used for all diseases; although these interventions are remarkably effective for relapsed chronic myelogenous leukemia, they have limited efficacy in other hematologic malignancies. Conventional and novel chemotherapy, monoclonal antibody therapy, targeted therapies, and second transplants have been utilized in a variety of relapsed diseases, but reports on these therapies are generally anecdotal and retrospective. As such, there is an immediate need for well-designed, disease-specific trials for treatment of relapse after alloHSCT. This report summarizes current treatment options under investigation for relapse after alloHSCT in a disease-specific manner. In addition, recommendations are provided for specific areas of research necessary in the treatment of relapse after alloHSCT.

Type: Article
Title: NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
DOI: 10.1016/j.bbmt.2010.08.001
Keywords: Allogeneic hematopoietic stem cell transplantation, Treatment, Donor lymphocyte infusion, CHRONIC LYMPHOCYTIC-LEUKEMIA, ACUTE LYMPHOBLASTIC-LEUKEMIA, BONE-MARROW-TRANSPLANTATION, GRAFT-VERSUS-LEUKEMIA, CHRONIC MYELOID-LEUKEMIA, DONOR LEUKOCYTE INFUSIONS, CHRONIC MYELOGENOUS LEUKEMIA, NON-HODGKIN-LYMPHOMA, MINIMAL RESIDUAL DISEASE, MINOR HISTOCOMPATIBILITY ANTIGENS
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: http://discovery.ucl.ac.uk/id/eprint/171994
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item